Structure Therapeutics Inc (GPCR)
33.41
+3.31
(+11.00%)
USD |
NASDAQ |
Nov 22, 16:00
33.44
+0.03
(+0.09%)
After-Hours: 20:00
Structure Therapeutics Free Cash Flow: -104.33M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -104.33M |
| June 30, 2024 | -105.32M |
| March 31, 2024 | -95.59M |
| December 31, 2023 | -81.66M |
| Date | Value |
|---|---|
| September 30, 2023 | -70.87M |
| June 30, 2023 | -60.04M |
| March 31, 2023 | -53.00M |
| December 31, 2022 | -46.28M |
Free Cash Flow Range, Past 5 Years
-105.32M
Minimum
Jun 2024
-46.28M
Maximum
Dec 2022
-77.14M
Average
-76.26M
Median
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -74.25M |
| Eli Lilly and Co | -2.275B |
| Novo Nordisk AS | 9.828B |
| Pfizer Inc | 8.227B |
| Amgen Inc | 6.283B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.70M |
| Cash from Investing (Quarterly) | -189.04M |
| Cash from Financing (Quarterly) | -0.757M |
| Free Cash Flow Per Share (Quarterly) | -0.3562 |
| Free Cash Flow Yield | -6.26% |